These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3497903)

  • 1. Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study.
    Hagan JJ; Yost FJ; Nickoloff EL
    Invest Radiol; 1987 Jun; 22(6):490-4. PubMed ID: 3497903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the kallikrein-kinin and complement system in angiography using non-ionic contrast media].
    Hoffmeister HM; Fuhrer G; Pirschel J; Heller W
    Klin Wochenschr; 1988 Sep; 66(17):760-3. PubMed ID: 3263537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.
    Colman RW; Schmaier AH
    Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prekallikrein activation in the adult respiratory distress syndrome.
    Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
    Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of the kallikrein-kinin system by intravenous administration of ionic and non-ionic radiographic contrast media].
    Hoffmeister HM; Fuhrer G; Abels GA; Pirschel J; Heller W
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1138-41. PubMed ID: 3260554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
    Lewin MF; Kaplan AP; Harpel PC
    J Biol Chem; 1983 May; 258(10):6415-21. PubMed ID: 6343376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.